,,ii #aacth ,,congress #ast ,session ,s4 #ageh ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,november #ba1 #bjac,ms4 ,baldwin 7for herself and ,mr4 ,thune7 introduced the following bill2 which was read twice and referred to the ,committee on ,finance ,a ,,bill ,to amend title ,,xviii of the ,social ,security ,act to increase access to ,medicare data4 #a4 ,short title ,this ,act may be cited as the ,quality ,data1 ,quality ,healthcare ,act of #bjac4 #b4 ,expanding the availability of medicare data 7a7 ,expanding use of medicare data by qualified entities ,section #ahgd7;e7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciekk7e77 is amended-- 7#a7 in paragraph 7#c71 in the first sentence1 by inserting or1 such claims data in sufficient detail to identify cost and utilization1 as appropriate before the period at the end2 and 7#b7 by adding at the end the following new paragraph3 7#e7 ,expanding use of medicare data by qualified entities 7,a7 ,in general ,beginning ,january #a1 #bjad1 notwithstanding paragraph 7#d77;,b7 and the second sentence of paragraph 7#d77;,d71 a qualified entity may-- 7i7 use data received by such entity under this section1 and information derived from the evaluation described in paragraph 7#d77;,d71 for additional non-public analyses 7as determined appropriate by the ,secretary72 or 7ii7 subject to subparagraph 7,c71 provide or sell such data and analyses to entities described in subparagraph 7,b7 for non-public use 7including for the purposes of assisting providers of services and suppliers to develop and participate in quality and patient care improvement activities1 including developing new models of care74 7,b7 ,entities described ,the entities described in this subparagraph are the following3 7i7 ,a health care provider4 7ii7 ,a health insurance issuer 7as defined in section #bgia of the ,public ,health ,service ,act74 7iii7 ,an employer 7as defined in section #c7e7 of the ,employee ,retirement ,insurance ,security ,act of #aigd74 7iv7 ,any organization affiliated with or representing an entity described in clause 7i71 7ii71 or 7iii71 such as a medical society4 7v7 ,a public health authority 7as defined for purposes of the ,health ,insurance ,portability and ,accountability ,act of #aiif74 7vi7 ,a ,state or local government agency4 7vii7 ,a research organization that certifies that it will only use the data or analyses for the public good and not for proprietary purposes4 7viii7 ,any other entity the ,secretary determines appropriate to further the goals of this paragraph4 7,c7 ,requirements 7i7 ,data use agreement ,a qualified entity may only provide data or analysis to an entity under subparagraph 7,a77ii7 pursuant to a data use agreement with the entity4 ,under such agreement1 the entity-- 7,i7 may not re-sell such data or analyses2 and 7,,ii7 shall comply with the privacy and security policies of the qualified entity in using such data or analyses4 7ii7 ,civil money penalty 7,i7 ,in general ,if the ,secretary determines that an entity described in subparagraph 7,b7 knowingly used such data and analyses for purposes other than as authorized under this paragraph1 the entity shall be subject to a civil money penalty in an amount determined by the ,secretary for each such violation4 7,,ii7 ,procedures ,the provisions of section #aabh;,a 7other than subsections 7a7 and 7b7 of such section7 shall apply to a civil money penalty under subclause 7,i7 in the same manner as such provisions apply to a penalty or proceeding under section #aabh;,a7a74 4 7b7 ,access to medicare data to qualified clinical data registries ,to facilitate quality improvement ,section #ahdh7m77#c77;,e7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#d7m77#c77;,e77 is amended by adding at the end the following new clause3 7vi7 ,access to medicare data to facilitate quality improvement 7,i7 ,in general ,consistent with applicable laws and regulations with respect to privacy and other relevant matters1 beginning ,january #a1 #bjad1 the ,secretary shall1 subject to subclause 7,,ii71 provide claims data under this title 7in a form and manner determined to be appropriate7 to qualified clinical data registries under this subparagraph for purposes of linking such data with clinical outcomes data and preforming and disseminating risk-adjusted1 scientifically valid research to support quality improvement4 7,,ii7 ,limitation ,a qualified clinical data registry may not publicly report any data made available under subclause 7,i7 that individually identifies a provider of services or supplier unless the registry obtains the consent of the provider of services or supplier prior to such reporting4 4